{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020209","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.677059+00:00","generated_at":"2026-05-18T05:38:01.394500+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NanoVibronix shareholders approve reverse stock split with 1:2 to 1:50 range","bullets":["Reverse stock split amendment approved: ratio of 1-for-2 to 1-for-50, at Board discretion, within one year.","Votes: 550,179 for, 183,224 against, 33,836 abstentions.","Adjournment proposal approved (573,509 for, 166,066 against) but not needed.","Special meeting held July 17, 2025; previously adjourned from July 11."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020209","json":"https://secwatch.observer/filing/0001641172-25-020209.json","markdown":"https://secwatch.observer/filing/0001641172-25-020209.md","text":"https://secwatch.observer/filing/0001641172-25-020209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/0001641172-25-020209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:38:01.394500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}